SAB Biotherapeutics to Host Virtual 2022 Annual R&D Portfolio Update
August 04, 2022 08:30 ET
|
SAB Biotherapeutics, Inc.
SIOUX FALLS, S.D., Aug. 04, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (NASDAQ: SABS), a clinical-stage biopharmaceutical company with a first of its kind immunotherapy platform that produces...
Emerging Singlecell Technology Startups Report 2022: Analysis of 38 Early- Pre-Commercial Stage SCT Startups
July 27, 2022 04:48 ET
|
Research and Markets
Dublin, July 27, 2022 (GLOBE NEWSWIRE) -- The "Emerging Singlecell Technology Startups 2022" report has been added to ResearchAndMarkets.com's offering. The global single-cell technology (SCT)...
Global Singlecell Technology Market Landscape Report 2022: Market Share is Highly Concentrated on the Four Major Companies - 10x Genomics, Fluidigm, BD Biosciences, and Berkeley Light
July 20, 2022 07:08 ET
|
Research and Markets
Dublin, July 20, 2022 (GLOBE NEWSWIRE) -- The "Singlecell Technology Market Landscape 2022" report has been added to ResearchAndMarkets.com's offering. The global single-cell technology (SCT)...
Global Digital Biomanufacturing Market Report 2022-2031: Shift Toward Digitalization and Biomanufacturing in the Healthcare Industry Driving Growth
June 30, 2022 06:43 ET
|
Research and Markets
Dublin, June 30, 2022 (GLOBE NEWSWIRE) -- The "Digital Biomanufacturing Market - A Global and Regional Analysis: Analysis and Forecast, 2022-2031" report has been added to ResearchAndMarkets.com's...
Insights on the Mass Spectrometry Global Market to 2027 - United States to See Significant Growth
June 23, 2022 06:53 ET
|
Research and Markets
Dublin, June 23, 2022 (GLOBE NEWSWIRE) -- The "Mass Spectrometry Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering. Mass spectrometry is a process...
AGC Biologics’ Longmont General Manager, Tony Fraij, Joins Colorado BioScience Association Board of Directors
June 06, 2022 09:03 ET
|
AGC Biologics
SEATTLE, June 06, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Tony...
SAB Biotherapeutics Announces Appointment of Alexandra Kropotova, M.D., as Chief Medical Officer
June 06, 2022 08:30 ET
|
SAB Biotherapeutics, Inc.
SIOUX FALLS, S.D., June 06, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces...
2022 Flow Cytometry Life Science Market Landscape: Key Market Indicators for the Flow Cytometry Market as a Whole
May 30, 2022 04:23 ET
|
Research and Markets
Dublin, May 30, 2022 (GLOBE NEWSWIRE) -- The "2022 Flow Cytometry Life Science Dashboard Series 2 (NA & EMEA)" report has been added to ResearchAndMarkets.com's offering. This 2022 Dashboard...
Concept Companies Leads Development Efforts on Second Phase for Lacerta Therapeutics in Alachua's Progress District
May 27, 2022 14:00 ET
|
Concept Companies
GAINESVILLE, Fla., May 27, 2022 (GLOBE NEWSWIRE) -- Concept Companies, a national commercial real estate developer specializing in turnkey projects, announces the commencement of the design and...
SAB Biotherapeutics Provides Company Update for Q1 2022 Financial Results
May 12, 2022 16:15 ET
|
SAB Biotherapeutics, Inc.
Full data from Phase 2a trial that evaluated SAB-176 for treatment of seasonal influenza expected third quarter 2022 – first clinical data set from novel platform Phase 2 data for SAB-185 expected to...